Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
AquaNab secures funding from Nordic Foodtech VC to advance its nanoantibody platform for treating sea lice, enhancing sustainable aquaculture.
PRIVATEAug 11, 2026•about 4 hours ago
Round Type
Venture - Series Unknown
GermanyBiotechnology
Investors
Nordic Foodtech Vc
Description
Hamburg-based AquaNab has secured investment from Nordic Foodtech VC to advance its nanoantibody platform. This funding will assist in developing precision immunotherapies for aquaculture, particularly targeting sea lice. AquaNab aims to provide alternatives to existing treatment methods for fish health. CEO Dr
Company Information
Company
AquaNab
Location
Germany
About
AquaNab is a Hamburg-based biotechnology startup focused on developing precision immunotherapies for aquaculture, initially targeting sea lice in salmon farming. Founded by Dr. Ruth Tamara Montero, Dr. Alejandro Rojas Fernandez, and Gunnar Johildarson, the company aims to improve animal welfare and enhance fish health through innovative nanoantibody treatments. Their products are designed to be less invasive and to address significant challenges in the aquaculture industry.